The Cooper Companies, Inc. (COO)
USD 77.69
(3.08%)
USD 77.69
(3.08%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.52 Billion USD | 7.36% |
| 2022 | 2.35 Billion USD | 44.42% |
| 2021 | 1.62 Billion USD | 0.44% |
| 2020 | 1.62 Billion USD | 28.36% |
| 2019 | 1.26 Billion USD | -36.42% |
| 2018 | 1.98 Billion USD | 72.77% |
| 2017 | 1.14 Billion USD | 3.78% |
| 2016 | 1.1 Billion USD | -0.19% |
| 2015 | 1.1 Billion USD | -13.38% |
| 2014 | 1.28 Billion USD | 324.58% |
| 2013 | 301.67 Million USD | -13.42% |
| 2012 | 348.42 Million USD | 6.4% |
| 2011 | 327.45 Million USD | -44.68% |
| 2010 | 591.97 Million USD | -23.28% |
| 2009 | 771.63 Million USD | -10.46% |
| 2008 | 861.78 Million USD | 3.81% |
| 2007 | 830.11 Million USD | 21.85% |
| 2006 | 681.28 Million USD | 7.69% |
| 2005 | 632.65 Million USD | 336.72% |
| 2004 | 144.86 Million USD | -12.31% |
| 2003 | 165.2 Million USD | 29.76% |
| 2002 | 127.31 Million USD | 110.26% |
| 2001 | 60.55 Million USD | 50.42% |
| 2000 | 40.25 Million USD | -29.5% |
| 1999 | 57.1 Million USD | -27.45% |
| 1998 | 78.7 Million USD | 764.84% |
| 1997 | 9.1 Million USD | -81.0% |
| 1996 | 47.9 Million USD | 10.11% |
| 1995 | 43.5 Million USD | -5.84% |
| 1994 | 46.2 Million USD | -3.95% |
| 1993 | 48.1 Million USD | -17.92% |
| 1992 | 58.6 Million USD | 20.33% |
| 1991 | 48.7 Million USD | -31.31% |
| 1990 | 70.9 Million USD | -31.1% |
| 1989 | 102.9 Million USD | -69.47% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 2.58 Billion USD | -2.98% |
| 2024 Q1 | 2.72 Billion USD | 7.89% |
| 2024 Q2 | 2.66 Billion USD | -2.01% |
| 2023 FY | 2.52 Billion USD | 7.36% |
| 2023 Q3 | 2.51 Billion USD | -1.99% |
| 2023 Q2 | 2.56 Billion USD | -2.34% |
| 2023 Q1 | 2.62 Billion USD | 11.76% |
| 2023 Q4 | 2.52 Billion USD | 0.36% |
| 2022 Q2 | 2.57 Billion USD | -0.57% |
| 2022 Q4 | 2.35 Billion USD | -8.26% |
| 2022 FY | 2.35 Billion USD | 44.42% |
| 2022 Q1 | 2.58 Billion USD | 58.96% |
| 2022 Q3 | 2.56 Billion USD | -0.4% |
| 2021 Q3 | 1.41 Billion USD | -9.53% |
| 2021 Q4 | 1.62 Billion USD | 14.91% |
| 2021 Q2 | 1.56 Billion USD | -5.67% |
| 2021 Q1 | 1.65 Billion USD | 2.42% |
| 2021 FY | 1.62 Billion USD | 0.44% |
| 2020 FY | 1.62 Billion USD | 28.36% |
| 2020 Q4 | 1.62 Billion USD | 3.6% |
| 2020 Q3 | 1.56 Billion USD | -0.83% |
| 2020 Q1 | 1.47 Billion USD | 16.81% |
| 2020 Q2 | 1.57 Billion USD | 6.96% |
| 2019 Q2 | 1.47 Billion USD | -12.72% |
| 2019 Q3 | 1.42 Billion USD | -3.38% |
| 2019 FY | 1.26 Billion USD | -36.42% |
| 2019 Q4 | 1.26 Billion USD | -11.25% |
| 2019 Q1 | 1.68 Billion USD | -15.05% |
| 2018 FY | 1.98 Billion USD | 72.77% |
| 2018 Q2 | 2.44 Billion USD | 2.93% |
| 2018 Q3 | 2.24 Billion USD | -7.92% |
| 2018 Q4 | 1.98 Billion USD | -11.7% |
| 2018 Q1 | 2.37 Billion USD | 106.46% |
| 2017 Q1 | 1.2 Billion USD | 8.45% |
| 2017 Q3 | 1.18 Billion USD | -12.31% |
| 2017 Q4 | 1.14 Billion USD | -2.6% |
| 2017 FY | 1.14 Billion USD | 3.78% |
| 2017 Q2 | 1.34 Billion USD | 12.04% |
| 2016 FY | 1.1 Billion USD | -0.19% |
| 2016 Q4 | 1.1 Billion USD | -21.59% |
| 2016 Q3 | 1.41 Billion USD | 0.08% |
| 2016 Q2 | 1.41 Billion USD | 6.05% |
| 2016 Q1 | 1.33 Billion USD | 19.93% |
| 2015 Q1 | 1.3 Billion USD | 1.69% |
| 2015 Q4 | 1.1 Billion USD | 3.66% |
| 2015 Q3 | 1.07 Billion USD | -3.19% |
| 2015 Q2 | 1.1 Billion USD | -15.12% |
| 2015 FY | 1.1 Billion USD | -13.38% |
| 2014 Q3 | 301.44 Million USD | -0.02% |
| 2014 Q2 | 301.5 Million USD | -0.03% |
| 2014 Q1 | 301.58 Million USD | -0.03% |
| 2014 Q4 | 1.28 Billion USD | 324.89% |
| 2014 FY | 1.28 Billion USD | 324.58% |
| 2013 Q2 | 291.54 Million USD | -22.77% |
| 2013 Q4 | 301.67 Million USD | 40.12% |
| 2013 Q3 | 215.29 Million USD | -26.16% |
| 2013 FY | 301.67 Million USD | -13.42% |
| 2013 Q1 | 377.51 Million USD | 8.35% |
| 2012 Q2 | 275.09 Million USD | -25.87% |
| 2012 Q1 | 371.11 Million USD | 13.33% |
| 2012 Q4 | 348.42 Million USD | -23.29% |
| 2012 FY | 348.42 Million USD | 6.4% |
| 2012 Q3 | 454.22 Million USD | 65.12% |
| 2011 Q3 | 406.48 Million USD | -22.44% |
| 2011 FY | 327.45 Million USD | -44.68% |
| 2011 Q4 | 327.45 Million USD | -19.44% |
| 2011 Q1 | 586.72 Million USD | -0.89% |
| 2011 Q2 | 524.11 Million USD | -10.67% |
| 2010 Q1 | 724.17 Million USD | -6.15% |
| 2010 Q3 | 624.37 Million USD | -10.72% |
| 2010 Q4 | 591.97 Million USD | -5.19% |
| 2010 Q2 | 699.38 Million USD | -3.42% |
| 2010 FY | 591.97 Million USD | -23.28% |
| 2009 Q1 | 871.36 Million USD | 1.11% |
| 2009 Q2 | 848.37 Million USD | -2.64% |
| 2009 FY | 771.63 Million USD | -10.46% |
| 2009 Q4 | 771.63 Million USD | -3.61% |
| 2009 Q3 | 800.52 Million USD | -5.64% |
| 2008 Q2 | 901.78 Million USD | 2.68% |
| 2008 FY | 861.78 Million USD | 3.81% |
| 2008 Q1 | 878.25 Million USD | 5.8% |
| 2008 Q4 | 861.78 Million USD | -3.26% |
| 2008 Q3 | 890.86 Million USD | -1.21% |
| 2007 Q1 | 817.51 Million USD | 20.0% |
| 2007 FY | 830.11 Million USD | 21.85% |
| 2007 Q4 | 830.11 Million USD | 2.79% |
| 2007 Q3 | 807.58 Million USD | -1.21% |
| 2007 Q2 | 817.44 Million USD | -0.01% |
| 2006 Q1 | 727.23 Million USD | 14.95% |
| 2006 FY | 681.28 Million USD | 7.69% |
| 2006 Q2 | 698.18 Million USD | -3.99% |
| 2006 Q3 | 698.44 Million USD | 0.04% |
| 2006 Q4 | 681.28 Million USD | -2.46% |
| 2005 Q2 | 689.45 Million USD | -4.64% |
| 2005 FY | 632.65 Million USD | 336.72% |
| 2005 Q3 | 680.82 Million USD | -1.25% |
| 2005 Q4 | 632.65 Million USD | -7.08% |
| 2005 Q1 | 723.03 Million USD | 399.11% |
| 2004 Q4 | 144.86 Million USD | -3.26% |
| 2004 FY | 144.86 Million USD | -12.31% |
| 2004 Q3 | 149.74 Million USD | -3.31% |
| 2004 Q2 | 154.87 Million USD | -3.21% |
| 2004 Q1 | 160.01 Million USD | -3.14% |
| 2003 Q4 | 165.2 Million USD | -2.28% |
| 2003 Q2 | 141.94 Million USD | -10.71% |
| 2003 Q3 | 169.05 Million USD | 19.1% |
| 2003 FY | 165.2 Million USD | 29.76% |
| 2003 Q1 | 158.96 Million USD | 24.86% |
| 2002 Q1 | 36.81 Million USD | -39.21% |
| 2002 FY | 127.31 Million USD | 110.26% |
| 2002 Q4 | 127.31 Million USD | -5.93% |
| 2002 Q3 | 135.34 Million USD | 91.19% |
| 2002 Q2 | 70.79 Million USD | 92.3% |
| 2001 Q2 | 41.95 Million USD | 3.29% |
| 2001 Q4 | 60.55 Million USD | 32.81% |
| 2001 Q3 | 45.59 Million USD | 8.67% |
| 2001 Q1 | 40.62 Million USD | 0.9% |
| 2001 FY | 60.55 Million USD | 50.42% |
| 2000 FY | 40.25 Million USD | -29.5% |
| 2000 Q4 | 40.25 Million USD | -12.85% |
| 2000 Q1 | 57.5 Million USD | 0.7% |
| 2000 Q2 | 52.2 Million USD | -9.2% |
| 2000 Q3 | 46.19 Million USD | -11.52% |
| 1999 Q3 | 56.5 Million USD | -1.22% |
| 1999 Q2 | 57.2 Million USD | -26.38% |
| 1999 FY | 57.1 Million USD | -27.45% |
| 1999 Q4 | 57.1 Million USD | 1.06% |
| 1999 Q1 | 77.7 Million USD | -1.27% |
| 1998 Q1 | 63.8 Million USD | 601.1% |
| 1998 FY | 78.7 Million USD | 764.84% |
| 1998 Q4 | 78.7 Million USD | 3.01% |
| 1998 Q3 | 76.4 Million USD | 11.7% |
| 1998 Q2 | 68.4 Million USD | 7.21% |
| 1997 Q3 | 8.8 Million USD | -80.7% |
| 1997 Q4 | 9.1 Million USD | 3.41% |
| 1997 Q2 | 45.6 Million USD | 19.06% |
| 1997 Q1 | 38.3 Million USD | -20.04% |
| 1997 FY | 9.1 Million USD | -81.0% |
| 1996 Q4 | 47.9 Million USD | -0.42% |
| 1996 Q3 | 48.1 Million USD | -0.41% |
| 1996 FY | 47.9 Million USD | 10.11% |
| 1996 Q1 | 44.6 Million USD | 2.53% |
| 1996 Q2 | 48.3 Million USD | 8.3% |
| 1995 Q3 | 43.6 Million USD | -0.68% |
| 1995 Q4 | 43.5 Million USD | -0.23% |
| 1995 Q1 | 44.2 Million USD | -4.33% |
| 1995 FY | 43.5 Million USD | -5.84% |
| 1995 Q2 | 43.9 Million USD | -0.68% |
| 1994 Q3 | 46.7 Million USD | 33.81% |
| 1994 Q2 | 34.9 Million USD | -26.83% |
| 1994 Q4 | 46.2 Million USD | -1.07% |
| 1994 Q1 | 47.7 Million USD | -0.83% |
| 1994 FY | 46.2 Million USD | -3.95% |
| 1993 Q4 | 48.1 Million USD | 108.23% |
| 1993 Q2 | 53.1 Million USD | -0.19% |
| 1993 FY | 48.1 Million USD | -17.92% |
| 1993 Q3 | 23.1 Million USD | -56.5% |
| 1993 Q1 | 53.2 Million USD | -9.22% |
| 1992 Q2 | 49.3 Million USD | 0.41% |
| 1992 FY | 58.6 Million USD | 20.33% |
| 1992 Q4 | 58.6 Million USD | -10.26% |
| 1992 Q1 | 49.1 Million USD | 0.82% |
| 1992 Q3 | 65.3 Million USD | 32.45% |
| 1991 Q4 | 48.7 Million USD | 0.0% |
| 1991 Q3 | 48.7 Million USD | -12.09% |
| 1991 Q2 | 55.4 Million USD | -22.19% |
| 1991 Q1 | 71.2 Million USD | 0.42% |
| 1991 FY | 48.7 Million USD | -31.31% |
| 1990 FY | 70.9 Million USD | -31.1% |
| 1990 Q4 | 70.9 Million USD | 0.0% |
| 1989 FY | 102.9 Million USD | -69.47% |
| 1989 Q4 | 102.9 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | -3253.709% |
| AngioDynamics, Inc. | 3.93 Million USD | -63972.1% |
| AtriCure, Inc. | 60.59 Million USD | -4065.168% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | -4075.988% |
| BioLife Solutions, Inc. | 18.31 Million USD | -13682.972% |
| Daxor Corporation | 755.65 Thousand USD | -333886.626% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | -52130.96% |
| Femasys Inc. | 4.25 Million USD | -59169.467% |
| GlucoTrack, Inc. | 196 Thousand USD | -1287553.061% |
| Harvard Bioscience, Inc. | 30.7 Million USD | -8119.776% |
| Hologic, Inc. | 2.49 Billion USD | -1.069% |
| ICU Medical, Inc. | 1.57 Billion USD | -59.96% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 3174.056% |
| KORU Medical Systems, Inc. | 3.65 Million USD | -68989.877% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | -15081.665% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | -189.526% |
| Microbot Medical Inc. | 40 Thousand USD | -6309400.0% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -54960701.394% |
| Merit Medical Systems, Inc. | 823.01 Million USD | -206.654% |
| Nephros, Inc. | 1.39 Million USD | -181468.345% |
| NovoCure Limited | 596.24 Million USD | -323.285% |
| NEXGEL, Inc. | 513 Thousand USD | -491868.811% |
| NEXGEL, Inc. | 513 Thousand USD | -491868.811% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | -3637.634% |
| OraSure Technologies, Inc. | 11.38 Million USD | -22061.925% |
| Pro-Dex, Inc. | 7.53 Million USD | -33389.915% |
| Pulse Biosciences, Inc. | 8.08 Million USD | -31111.971% |
| Predictive Oncology Inc. | 2.18 Million USD | -115195.761% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | -130129.054% |
| QuidelOrtho Corporation | 2.27 Billion USD | -10.966% |
| Repligen Corporation | 510.14 Million USD | -394.724% |
| Sanara MedTech Inc. | 9.11 Million USD | -27594.129% |
| STAAR Surgical Company | 31.46 Million USD | -7920.466% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | -855425.424% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | -40.523% |
| Jin Medical International Ltd. | - USD | -Infinity% |